Dopamine promotes the neurodegenerative potential of β‐synuclein
Open Access
- 30 July 2020
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 156 (5) , 674-691
Abstract
A contribution of α‐Synuclein (α‐Syn) to etiology of Parkinson´s disease (PD) and Dementia with Lewy bodies (DLB) is currently undisputed, while the impact of the closely related β‐Synuclein (β‐Syn) on these disorders remains enigmatic. β‐Syn has long been considered to be an attenuator of the neurotoxic effects of α‐Syn, but in a rodent model of PD β‐Syn induced robust neurodegeneration in dopaminergic neurons of the substantia nigra. Given that dopaminergic nigral neurons are selectively vulnerable to neurodegeneration in PD, we now investigated if dopamine can promote the neurodegenerative potential of β‐Syn. We show that in cultured rodent and human neurons a dopaminergic neurotransmitter phenotype substantially enhanced β‐Syn‐induced neurodegeneration, irrespective if dopamine is synthesized within neurons or up‐taken from extracellular space. Nuclear magnetic resonance interaction and thioflavin‐T incorporation studies demonstrated that dopamine and its oxidized metabolites 3,4‐dihydroxyphenylacetaldehyde (DOPAL) and dopaminochrome (DCH) directly interact with β‐Syn, thereby enabling structural and functional modifications. Interaction of DCH with β‐Syn inhibits its aggregation, which might result in increased levels of neurotoxic oligomeric β‐Syn. Since protection of outer mitochondrial membrane integrity prevented the additive neurodegenerative effect of dopamine and β‐Syn, such oligomers might act at a mitochondrial level similar to what is suggested for α‐Syn. In conclusion, our results suggest that β‐Syn can play a significant pathophysiological role in etiology of PD through its interaction with dopamine metabolites and thus should be re‐considered as a disease‐relevant factor, at least for those symptoms of PD that depend on degeneration of nigral dopaminergic neurons. imageKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Max-Planck-Gesellschaft
- Max-Planck-Gesellschaft (1‐390729940)
- Universität zu Lübeck
- Università degli Studi di Padova
This publication has 59 references indexed in Scilit:
- Complexity of dopamine metabolismCell Communication and Signaling, 2013
- β‐synuclein aggregates and induces neurodegeneration in dopaminergic neuronsAnnals of Neurology, 2013
- The renaissance of mitochondrial pHJournal of General Physiology, 2012
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease modelsThe EMBO Journal, 2009
- Structural characterization of α‐synuclein in an aggregation prone stateProtein Science, 2009
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra NeuronsNeuron, 2009
- Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC RegionPLOS ONE, 2008
- Structural Characterization of the Intrinsically Unfolded Protein β-Synuclein, a Natural Negative Regulator of α-Synuclein AggregationJournal of Molecular Biology, 2007
- Biophysical Properties of the Synucleins and Their Propensities to FibrillateJournal of Biological Chemistry, 2002